Urogen Pharma (URGN)
(Delayed Data from NSDQ)
$13.78 USD
+0.81 (6.25%)
Updated May 15, 2024 04:00 PM ET
After-Market: $13.73 -0.05 (-0.36%) 7:58 PM ET
4-Sell of 5 4
F Value A Growth D Momentum D VGM
Industry / Sector Report
Industry : Medical - Biomedical and Genetics
Zacks Industry Rank
Top 37% (89 out of 250)Zacks Sector Rank
Top 25% (4 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.40 | 1.35 | 9.99 |
Current Quarter Estimate | -0.89 | 7.43 | 57.00 |
Year Ago Quarter Estimate | -1.03 | 0.12 | 52.54 |
Next Quarter Estimate | -0.90 | 7.81 | 61.00 |
Next Year Estimate | -1.72 | 37.76 | 270.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | -1.13 | 13.10 | 15.67 |
Next Year | 52.09 | 8.30 | 9.31 |
Last 5 Years | NA | 1.00 | 8.10 |
Next 5 Years | NA | 20.10 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | NA | -2.18 |
Price/Book (MRQ) | NA | 2.10 |
Price/Cash Flow (MRFY) | NA | 16.35 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | -123.74% | -88.73% |
Return on Equity (TTM) | NA | -44.24% |
Debt to Equity (MRQ) | NA | 0.00 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.